| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1057: Relugolix–estradiol–norethisterone for treating symptoms of endometriosis |
|
Medicine details |
|
| Medicine name | Relugolix / estradiol / norethisterone (Ryeqo) |
| Formulation | 40 mg/ 1 mg /0.5 mg film-coated tablets |
| Reference number | 3642 |
| Indication | Treatment of symptoms of endometriosis |
| Company | Gedeon Richter (UK) Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 13/02/2025 |
| NICE guidance | TA1057: Relugolix–estradiol–norethisterone for treating symptoms of endometriosis |